AMSTERDAM--(BUSINESS WIRE)-- LSP Advisory B.V., a group company of LSP, one of Europe’s largest and most reputable specialized healthcare and biotechnology investment firms, today announced the initial public offering of the LSP Life Sciences Fund N.V. (the “Fund”) on NYSE Euronext Amsterdam.
